| Primary |
| Salivary Hypersecretion |
23.4% |
| Motion Sickness |
21.0% |
| Nausea |
8.4% |
| Prophylaxis Against Motion Sickness |
6.6% |
| Hypertension |
5.4% |
| Chronic Obstructive Pulmonary Disease |
4.8% |
| Constipation |
3.6% |
| Increased Bronchial Secretion |
3.0% |
| Prophylaxis |
3.0% |
| Prophylaxis Of Nausea And Vomiting |
3.0% |
| Antiplatelet Therapy |
2.4% |
| Schizophrenia |
2.4% |
| Vomiting |
2.4% |
| Dizziness |
1.8% |
| Drooling |
1.8% |
| Palliative Care |
1.8% |
| Secretion Discharge |
1.8% |
| Affective Disorder |
1.2% |
| Agitation |
1.2% |
| Bronchial Obstruction |
1.2% |
|
| Off Label Use |
15.7% |
| Wrong Technique In Drug Usage Process |
14.6% |
| Tachycardia |
6.7% |
| Visual Impairment |
6.7% |
| Somnolence |
5.6% |
| Vision Blurred |
5.6% |
| Vomiting |
5.6% |
| Tremor |
4.5% |
| Vertigo |
4.5% |
| Dizziness |
3.4% |
| Dry Mouth |
3.4% |
| Overdose |
3.4% |
| Post Procedural Complication |
3.4% |
| Psychotic Disorder |
3.4% |
| Concomitant Disease Progression |
2.2% |
| Decreased Insulin Requirement |
2.2% |
| Delirium |
2.2% |
| Diplopia |
2.2% |
| Headache |
2.2% |
| Incoherent |
2.2% |
|
| Secondary |
| Product Used For Unknown Indication |
13.0% |
| Pain |
10.1% |
| Nausea |
9.1% |
| Constipation |
7.5% |
| General Anaesthesia |
7.3% |
| Depression |
5.7% |
| Hypertension |
5.3% |
| Prophylaxis |
5.3% |
| Drug Use For Unknown Indication |
5.0% |
| Bacterial Infection |
4.7% |
| Vomiting |
4.4% |
| Anxiety |
3.9% |
| Proctalgia |
3.1% |
| Anaesthesia |
3.0% |
| Schizophrenia |
3.0% |
| Salivary Hypersecretion |
2.3% |
| Blood Cholesterol Increased |
1.8% |
| Chronic Obstructive Pulmonary Disease |
1.8% |
| Prophylaxis Of Nausea And Vomiting |
1.8% |
| Thrombosis Prophylaxis |
1.8% |
|
| White Blood Cell Count Increased |
16.3% |
| Abdominal Pain |
10.5% |
| Anticholinergic Syndrome |
7.0% |
| Toxic Epidermal Necrolysis |
7.0% |
| Vomiting |
7.0% |
| Dry Mouth |
5.8% |
| Neutropenia |
4.7% |
| Unresponsive To Stimuli |
4.7% |
| Completed Suicide |
3.5% |
| Drug Hypersensitivity |
3.5% |
| Dysarthria |
3.5% |
| Hallucination |
3.5% |
| Liver Function Test Abnormal |
3.5% |
| Pneumonia Fungal |
3.5% |
| Rash Erythematous |
3.5% |
| White Blood Cell Count Decreased |
3.5% |
| Agitation |
2.3% |
| Agranulocytosis |
2.3% |
| Anaemia |
2.3% |
| Clostridium Difficile Colitis |
2.3% |
|
| Concomitant |
| Product Used For Unknown Indication |
32.9% |
| Pain |
7.4% |
| Nausea |
6.9% |
| Prophylaxis |
6.7% |
| Drug Use For Unknown Indication |
5.6% |
| Anxiety |
4.9% |
| Back Pain |
4.1% |
| Vomiting |
3.7% |
| Constipation |
3.7% |
| Abdominal Pain |
3.4% |
| Hypertension |
3.3% |
| Crohn's Disease |
3.2% |
| Acute Lymphocytic Leukaemia |
3.2% |
| Pyrexia |
1.8% |
| Supportive Care |
1.8% |
| Breast Cancer |
1.6% |
| Insomnia |
1.6% |
| Premedication |
1.5% |
| Depression |
1.4% |
| Acute Myeloid Leukaemia |
1.3% |
|
| Vomiting |
14.5% |
| Weight Decreased |
7.0% |
| Death |
6.6% |
| Pulmonary Embolism |
6.2% |
| Nausea |
5.3% |
| Pyrexia |
5.3% |
| Renal Colic |
5.3% |
| Renal Failure Acute |
5.3% |
| Thrombocytopenia |
5.3% |
| Wound Complication |
4.4% |
| Pancreatitis |
4.0% |
| Abdominal Pain |
3.5% |
| Dyspnoea |
3.5% |
| Narcotic Intoxication |
3.5% |
| Pneumonia |
3.5% |
| Unevaluable Event |
3.5% |
| White Blood Cell Count Decreased |
3.5% |
| Wound Infection Staphylococcal |
3.5% |
| Diarrhoea |
3.1% |
| Pleural Effusion |
3.1% |
|
| Interacting |
| Product Used For Unknown Indication |
67.8% |
| Anaesthesia |
6.9% |
| Constipation |
5.7% |
| Gastric Ulcer |
3.4% |
| Lung Disorder |
3.4% |
| Pain |
3.4% |
| Restless Legs Syndrome |
3.4% |
| Anaesthetic Premedication |
1.1% |
| Depression |
1.1% |
| Nerve Block |
1.1% |
| Obsessive-compulsive Disorder |
1.1% |
| Prophylaxis Of Nausea And Vomiting |
1.1% |
|
| Drug Interaction |
20.0% |
| Oliguria |
20.0% |
| Anticholinergic Syndrome |
10.0% |
| Disorientation |
10.0% |
| Fall |
10.0% |
| Infectious Peritonitis |
10.0% |
| Peritonitis |
10.0% |
| Tachycardia |
10.0% |
|
